| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS… |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | — | |
| 2026 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | — | |
| 2026 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$60,000 | — | |
| 2026 | TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS… |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | — | |
| 2025 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$60,000 | — | |
| 2025 | TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS… |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | — | |
| 2025 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$60,000 | — | |
| 2025 | TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS… |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | — | |
| 2025 | TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS… |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | — | |
| 2025 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 9 | $480,000 |
| TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS | 9 | $400,000 |
| Name | Disclosed Prior Position |
|---|---|
| ANNE ELIZABETH ESPOSITO | Health Policy Coordinator, Energy and Commerce Committee; Health Policy Advisor, Health Subcommittee (Chairman Biliraki… |